ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

GAO Report To Include Some But Not all Of Obey’s Charges

June 24, 1977

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007

Margaret Kripke Comes Out of Retirement To Become Chief Scientific Officer at CPRIT

December 14, 2012

Harkin Withdraws Amendment Allow NIH To Bypass INDS

October 9, 1992

NCI-Approved Protocols Listed

March 28, 2003

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

June 2, 2000